Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

AFFILIATE HELPS IAF EARNINGS

Aug. 14, 1991

CALGENE ASKS FDA TO APPROVE ITS TOMATO

Aug. 13, 1991

AVALON/SANDOZ FUND TO CREATE START-UPS

Aug. 13, 1991

GENTA RAISES $8.4 MILLION

Aug. 13, 1991

VESTAR, FUJISAWA END JOINT AGREEMENT

Aug. 13, 1991

HEMACARE CANCELS SALE OF PLASMA CENTERS

Aug. 13, 1991

START-UP PINS HOPES ON MACROPHAGES

Aug. 12, 1991

FINANCIAL BRIEFS

Aug. 12, 1991

GREENWICH PRIVATE PLACEMENT NETS $3.2 MILLION

Aug. 12, 1991

GENEX EXPLAINS PROTEIN G STABILITY

Aug. 12, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...